8 drug(s) with this reaction
48,849 total reports
Incorrect Dose Administered has been reported as an adverse reaction across 8 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 48,849 adverse event reports mention incorrect dose administered in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with incorrect dose administered, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have incorrect dose administered listed in their FDA adverse event reports, sorted by report count:
In addition to incorrect dose administered, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
8 drug(s) manufactured by Abbvie Inc have incorrect dose administered listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, FENOFIBRATE, RISANKIZUMAB-RZAA, and others.
There are a combined 48,849 reports of incorrect dose administered across 8 Abbvie Inc drug(s) in the FDA adverse event database.